Brief

The Drugs Controller General of India (DCGI) has classified newly notified medical devices into risk-based categories, with most falling under Class C (moderate to high risk) and some under Class B (low to moderate risk). This classification impacts regulatory compliance and safety oversight for medical device manufacturers and healthcare providers.

This content is restricted.

Highlights content goes here...

This content is restricted.

Central Drugs Standard Control Organization (CDSCO)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies